Company intelligence / Profile preview

Teliatry

Richardson, Texas, United Statesteliatry.com ↗

Ownership: Private
Development stage: Clinical

Overview

Teliatry has developed highly miniaturized, wireless implantable neuromodulation and sensing devices. Their ReStore platform includes a vagus nerve stimulator that has received FDA approval for pilot clinical studies in PTSD and spinal cord injury. The company is recognized for creating some of the smallest and most complex active implants globally, including a bionic eye system. They have demonstrated first-in-human use of their miniature IPGs and continue to develop next-generation AIMDs using advanced manufacturing techniques.

Therapeutic areas: PsychiatryOphthalmologyNeurology
Modalities: DeviceNeuromodulation systemImplantable pulse generator (IPG)Vagus nerve stimulator
Industry: Implantable Medical Devices

Partnerships

Texas Biomedical Device Center at University of Texas at DallasZyvex Labs

Beyond the preview

Go deeper on Teliatry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teliatry.

Explore the full profile